NASDAQ · Biotechnology

ORKA (ORKA) Stock

$93.41 -3.22% NASDAQ: ORKA Healthcare

Valuation

MetricValue
Price$93.41
Market Cap$3.50B
P/E Ratio-25.05
P/B Ratio6.72
P/S Ratio0.00
EPS (TTM)$-1.85
52-Week High$97.18
52-Week Low$8.91
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-24.69%
ROA-17.25%
ROCE-25.85%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio22.37

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-19.0M$-10.0M$-7.0M$-88.0M$-122.0M
Net Profit$-19.0M$-10.0M$-5.0M$-84.0M$-105.0M
EPS$-16.68$-8.27$-4.44$-4.99$-2.31
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$55.0M$43.0M$38.0M$396.0M$489.0M
Total Liabilities$4.0M$1.0M$1.0M$14.0M$17.0M
Cash$53.0M$42.0M$37.0M$62.0M$47.0M
Borrowings$0$0$0$1.0M$2.0M

Latest News

Oruka Therapeutics Insider Sold Shares Worth $846,180, According to a Recent SEC Filing MT Newswires · Jul 13, 2026 HMI Capital Pares Its Stake in AI Company nCino Barrons.com · Jul 10, 2026 Oruka Therapeutics Insider Sold Shares Worth $472,079, According to a Recent SEC Filing MT Newswires · Jul 2, 2026 H.C. Wainwright Keeps Buy Rating on Oruka (ORKA) After Apogee Acquisition News Insider Monkey · Jul 1, 2026 Oruka Therapeutics H2 ORKA-001 Data Could Further De-Risk Lead Program, UBS Says MT Newswires · Jul 1, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-19.0M$-11.0M—$-58.0M$-88.0M
Investing Cash Flow$0$0—$-330.0M$-97.0M
Financing Cash Flow$0$0—$0$0
Net Cash Flow$4.0M$-11.0M—$24.0M$-15.0M
Free Cash Flow$-19.0M$-11.0M$0$-58.0M$-88.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA-23.54
FCF Yield-3.65%
Quick Ratio22.37
Interest Coverage—
Return 1Y559.92%
Return 3Y604.74%
Return 5Y384.06%

Ownership

Insiders Held1.23%
Institutions Held89.70%
Institutions Float Held90.82%
Institutional HolderSharesReport Date
FMR, LLC7,431,4032026-03-31
Venrock Adviser, LLC4,148,4282026-03-31
Fairmount Funds Management LLC3,705,2622026-03-31
Blackrock Inc.3,527,0872026-03-31
Viking Global Investors, L.P.2,666,6902026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About ORKA

ORKA stock trades at $93.41 with a market capitalization of $3.50B. The stock is valued at a price-to-earnings (P/E) ratio of -25.05, price-to-book of 6.72, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $8.91 and $97.18, and currently trades 3.9% below its 52-week high.

On profitability, ORKA generates a return on equity (ROE) of -24.69%, return on capital employed of -25.85%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides